STOCK ALARM
PRO
SA
PRO
Explore
Screener
Alerts
Themes
Research
⌘
K
⌘
J
Pro
Sign In
Free Account
Themes
West Pharmaceutical Services, Inc.
WST
NYSE
Loading
Overview
Intelligence
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Income
Balance
Cash Flow
Annual
Quarterly
3Y
5Y
10Y
All
Revenue
$3B
↑6%
Gross Profit
$1B
↑10%
Operating Income
$617M
↑4%
Net Income
$494M
↑0%
EBITDA
$724M
↓3%
EPS Diluted
6.8
Cost of Revenue
$2B
Gross Margin %
35.9%
R&D Expenses
$74M
SG&A Expenses
$393M
Operating Expenses
$486M
Operating Margin %
20.1%
Interest Expense
$600K
Income Before Tax
$615M
Income Tax Expense
$122M
Net Margin %
16.1%
EPS
6.8
Shares Out (Diluted)
72.7M
Shares Out (Basic)
72.3M
Total Costs & Expenses
$2B
Interest Income
$18M
EBITDA Margin %
23.5%
Pre-Tax Margin %
20.0%
Other Income/Expenses
$-2M
Revenue CAGR (5Y)
+7.4%
Margin Trend
declining
Free Cash Flow
$0.5B
Profitability
Profitable
Metric
Dec 21
Dec 22
Dec 23
Dec 24
Dec 25
Revenue
2,831
2,886
↑1.9%
2,951
↑2.3%
2,893
↓2.0%
3,074
↑6.3%
Gross Profit
1,173
1,139
↓2.9%
1,133
↓0.5%
1,002
↓11.5%
1,103
↑10.1%
Operating Income
759
764
↑0.6%
711
↓6.9%
595
↓16.4%
617
↑3.8%
Net Income
662
586
↓11.5%
593
↑1.3%
493
↓17.0%
494
↑0.2%
EBITDA
880
808
↓8.1%
844
↑4.5%
744
↓11.9%
724
↓2.7%
EPS Diluted
8.67
7.73
↓10.8%
7.88
↑1.9%
6.69
↓15.1%
6.80
↑1.6%
Show all metrics
← Newer
1 / 2
Older →
Values in millions except EPS · Ratios shown as percentages